Delivery Order SPE2DB20D3101-SPE2DB23FRDG8

Award Date 2/23/23
Potential Completion Date 2/24/23
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,111.10, is for the delivery of Tetracaine 0.5% Eye Drops 5ML. It is a firm fixed price delivery order contract with an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no information...
This federal contract award, valued at $9,160.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of tetracaine 0.5% eye medication, with a performance period extending through June 3, 2025. The award is not set-aside and is a firm fixed-price delivery order contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,924.98 Firm Fixed Price delivery order is for the provision of 15 mL bottles of 0.5% Tetracaine eye drops. The award does not have a set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical on December 27, 2023. The contract is for the supply of 0.5% Tetracaine eye drops in 15ml bottles, with a ceiling value of $4,311.72 and a completion date of December 28, 2023. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 15 ml bottles of Tetracaine 0.5% eye drops, a type of topical anesthetic medication. The award has a ceiling value of $1,687.87 and is a firm fixed-price delivery order contract, with a performance period ending on May 15, 2025. The contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,471.69, is for the procurement of Tetracaine 0.5% Eye Drops (15 ml) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,127.68 firm fixed-price delivery order is for the supply of Tetracaine 0.5% Steri-Unit Solution, a topical anesthetic medication. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,774.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TETRACAINE 0.5% STERI-UNIT SOL 4ML, a medical product, with a completion date of February 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $1,938.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tetracaine 0.5% Steri-Unit Solution, a medical product used in various healthcare settings. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of TETRACAINE 0.5% EYE 1S medication with a ceiling value of $4,133.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. The contract is not designated with a set-aside and was awarded on...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRDG8
    Delivery Order

This federal contract award, valued at $1,820.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4560036231 - Tetracaine 0.5% Eye Drops, 15 ml, with a completion date of February 24, 2023.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:45 AM